Home > Press > Microfluidics nanotechnology expert selected to speak at particle characterization and processing seminar
Abstract:
Microfluidics, a wholly owned subsidiary of MFIC Corporation, announces that Dr. Thomai Panagiotou, Vice President of Research and Development at the company, will be a featured speaker at the Particle Characterization and Processing Seminar, March 20, 2008 at the Hyatt Regency La Jolla in San Diego, Calif. This educational seminar is free and will focus on applications, problem solving and new developments in particle size technology.
Panagiotou's session is titled, "Microfluidizer® High Shear Fluid Processing: Technology and Biopharmaceutical Applications."
As part of this session, attendees will be educated on Microfluidizer high shear fluid processing technology, which is used for particle size reduction of suspensions and emulsions to sub-micron levels, as well as cell disruption. Attendees will also learn about Microfluidics Reaction Technology (MRT) for the "bottom up" production of nanoparticles through chemical reactions and physical processes.
An acknowledged expert in nanotechnology, Panagiotou holds a MS and Ph.D. in Mechanical Engineering from Northeastern University.
To reserve your space at this free, educational seminar please contact Tom Costa at (310) 273-8339 or via email by March 14, 2008.
####
About Microfluidics
Microfluidics, a wholly owned subsidiary of MFIC Corporation, is a supplier of advanced fluid processing equipment and reaction technology for laboratory, pilot scale and manufacturing applications. Microfluidics is a leader in innovative technology and comprehensive solutions for formulations requiring repeatability and for the production of uniformly distributed nanoparticles.
Microfluidics has been a worldwide supplier of Microfluidizer® high shear fluid processing systems to the Biotechnology and Pharmaceutical industries since 1984. As leader in the field, Microfluidics has enabled numerous companies and institutions to formulate, validate and produce licensed drugs for the worldwide healthcare market.
Companies seeking to produce difficult-to-formulate products or to find better methods of bio-processing can take advantage of complimentary sample testing at one of three Microfluidics facilities. Visit www.microfluidicscorp.com, email or contact Microfluidics at 800.370.5452 for application information.
For more information, please click here
Contacts:
Katie DePorter
Gray & Rice Public Relations
617-367-0100 ext. 121
Copyright © Microfluidics
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Microfluidics/Nanofluidics
Implantable device shrinks pancreatic tumors: Taming pancreatic cancer with intratumoral immunotherapy April 14th, 2023
Researchers design new inks for 3D-printable wearable bioelectronics: Potential uses include printing electronic tattoos for medical tracking applications August 19th, 2022
Oregon State University research pushes closer to new therapy for pancreatic cancer May 6th, 2022
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Events/Classes
A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024
Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||